469 related articles for article (PubMed ID: 8728513)
1. Chemical and immunochemical comparison of protein adduct formation of four carboxylate drugs in rat liver and plasma.
Bailey MJ; Dickinson RG
Chem Res Toxicol; 1996; 9(3):659-66. PubMed ID: 8728513
[TBL] [Abstract][Full Text] [Related]
2. Disposition and covalent binding of diflunisal and diflunisal acyl glucuronide in the isolated perfused rat liver.
Wang M; Dickinson RG
Drug Metab Dispos; 1998 Feb; 26(2):98-104. PubMed ID: 9456294
[TBL] [Abstract][Full Text] [Related]
3. Studies on the metabolism of tolmetin to the chemically reactive acyl-coenzyme A thioester intermediate in rats.
Olsen J; Li C; Skonberg C; Bjørnsdottir I; Sidenius U; Benet LZ; Hansen SH
Drug Metab Dispos; 2007 May; 35(5):758-64. PubMed ID: 17303625
[TBL] [Abstract][Full Text] [Related]
4. Role of benoxaprofen and flunoxaprofen acyl glucuronides in covalent binding to rat plasma and liver proteins in vivo.
Dong JQ; Liu J; Smith PC
Biochem Pharmacol; 2005 Sep; 70(6):937-48. PubMed ID: 16046212
[TBL] [Abstract][Full Text] [Related]
5. Bile duct ligation promotes covalent drug-protein adduct formation in plasma but not in liver of rats given zomepirac.
Wang M; Dickinson RG
Life Sci; 2000 Dec; 68(5):525-37. PubMed ID: 11197750
[TBL] [Abstract][Full Text] [Related]
6. Dipeptidyl peptidase IV is a target for covalent adduct formation with the acyl glucuronide metabolite of the anti-inflammatory drug zomepirac.
Wang M; Gorrell MD; McGaughan GW; Dickinson RG
Life Sci; 2001 Jan; 68(7):785-97. PubMed ID: 11205870
[TBL] [Abstract][Full Text] [Related]
7. Limitations of hepatocytes and liver homogenates in modelling in vivo formation of acyl glucuronide-derived drug-protein adducts.
Bailey MJ; Dickinson RG
J Pharmacol Toxicol Methods; 1999 Feb; 41(1):27-32. PubMed ID: 10507755
[TBL] [Abstract][Full Text] [Related]
8. Hepatobiliary transport of diflunisal conjugates and taurocholate by the perfused rat liver: the effect of chronic exposure of rats to diflunisal.
Wang M; Dickinson RG
Life Sci; 1998; 62(8):751-62. PubMed ID: 9489511
[TBL] [Abstract][Full Text] [Related]
9. Studies on the reactivity of acyl glucuronides--III. Glucuronide-derived adducts of valproic acid and plasma protein and anti-adduct antibodies in humans.
Williams AM; Worrall S; de Jersey J; Dickinson RG
Biochem Pharmacol; 1992 Feb; 43(4):745-55. PubMed ID: 1540228
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo studies on acyl-coenzyme A-dependent bioactivation of zomepirac in rats.
Olsen J; Li C; Bjørnsdottir I; Sidenius U; Hansen SH; Benet LZ
Chem Res Toxicol; 2005 Nov; 18(11):1729-36. PubMed ID: 16300382
[TBL] [Abstract][Full Text] [Related]
11. Immunochemical identification of mouse hepatic protein adducts derived from the nonsteroidal anti-inflammatory drugs diclofenac, sulindac, and ibuprofen.
Wade LT; Kenna JG; Caldwell J
Chem Res Toxicol; 1997 May; 10(5):546-55. PubMed ID: 9168252
[TBL] [Abstract][Full Text] [Related]
12. Covalent binding of acidic drugs via reactive intermediates: detection of benoxaprofen and flunoxaprofen protein adducts in biological material.
Dahms M; Spahn-Langguth H
Pharmazie; 1996 Nov; 51(11):874-81. PubMed ID: 8985978
[TBL] [Abstract][Full Text] [Related]
13. Reactivity of gemfibrozil 1-o-beta-acyl glucuronide. Pharmacokinetics of covalently bound gemfibrozil-protein adducts in rats.
Sallustio BC; Foster DJ
Drug Metab Dispos; 1995 Sep; 23(9):892-9. PubMed ID: 8565777
[TBL] [Abstract][Full Text] [Related]
14. Evidence for the bioactivation of zomepirac and tolmetin by an oxidative pathway: identification of glutathione adducts in vitro in human liver microsomes and in vivo in rats.
Chen Q; Doss GA; Tung EC; Liu W; Tang YS; Braun MP; Didolkar V; Strauss JR; Wang RW; Stearns RA; Evans DC; Baillie TA; Tang W
Drug Metab Dispos; 2006 Jan; 34(1):145-51. PubMed ID: 16251255
[TBL] [Abstract][Full Text] [Related]
15. Studies on the reactivity of acyl glucuronides--V. Glucuronide-derived covalent binding of diflunisal to bladder tissue of rats and its modulation by urinary pH and beta-glucuronidase.
Dickinson RG; King AR
Biochem Pharmacol; 1993 Oct; 46(7):1175-82. PubMed ID: 8216368
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of proliferation of HT-29 colon adenocarcinoma cells by carboxylate NSAIDs and their acyl glucuronides.
Cannell GR; Vesey DA; Dickinson RG
Life Sci; 2001 Nov; 70(1):37-48. PubMed ID: 11764005
[TBL] [Abstract][Full Text] [Related]
17. Zomepirac acyl glucuronide covalently modifies tubulin in vitro and in vivo and inhibits its assembly in an in vitro system.
Bailey MJ; Worrall S; de Jersey J; Dickinson RG
Chem Biol Interact; 1998 Sep; 115(2):153-66. PubMed ID: 9826947
[TBL] [Abstract][Full Text] [Related]
18. Hepatic covalent adduct formation with zomepirac in the CD26-deficient mouse.
Wang M; Gorrell MD; Abbott CA; Jaggi R; Marguet D; Dickinson RG
J Gastroenterol Hepatol; 2002 Jan; 17(1):66-71. PubMed ID: 11895555
[TBL] [Abstract][Full Text] [Related]
19. Selective protein adducts to membrane proteins in cultured rat hepatocytes exposed to diclofenac: radiochemical and immunochemical analysis.
Kretz-Rommel A; Boelsterli UA
Mol Pharmacol; 1994 Feb; 45(2):237-44. PubMed ID: 8114673
[TBL] [Abstract][Full Text] [Related]
20. Immunochemical detection of covalently modified protein adducts in livers of rats treated with methyleugenol.
Gardner I; Bergin P; Stening P; Kenna JG; Caldwell J
Chem Res Toxicol; 1996 Jun; 9(4):713-21. PubMed ID: 8831815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
